Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to $15.5 million.

  • SeaStar Medical Holding's Liabilities and Shareholders Equity rose 23863.93% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.2 million, marking a year-over-year increase of 8766.19%. This contributed to the annual value of $4.7 million for FY2024, which is 3378.88% up from last year.
  • As of Q3 2025, SeaStar Medical Holding's Liabilities and Shareholders Equity stood at $15.5 million, which was up 23863.93% from $8.4 million recorded in Q2 2025.
  • SeaStar Medical Holding's Liabilities and Shareholders Equity's 5-year high stood at $15.5 million during Q3 2025, with a 5-year trough of $2.5 million in Q3 2023.
  • For the 3-year period, SeaStar Medical Holding's Liabilities and Shareholders Equity averaged around $5.8 million, with its median value being $4.6 million (2024).
  • Data for SeaStar Medical Holding's Liabilities and Shareholders Equity shows a peak YoY increase of 23863.93% (in 2025) and a maximum YoY decrease of 180.88% (in 2025) over the last 5 years.
  • SeaStar Medical Holding's Liabilities and Shareholders Equity (Quarter) stood at $3.5 million in 2023, then surged by 33.79% to $4.7 million in 2024, then surged by 230.43% to $15.5 million in 2025.
  • Its last three reported values are $15.5 million in Q3 2025, $8.4 million for Q2 2025, and $7.6 million during Q1 2025.